XASX
CAN
Market cap2mUSD
Oct 09, Last price
0.01AUD
1D
0.00%
1Q
50.00%
IPO
-99.10%
Name
Cann Group Ltd
Chart & performance
P/E
0.21
P/S
0.50
EPS
0.03
Div yield, %
—
Shrs. gr., 5y
36.25%
Rev. gr., 5y
14.81%
Revenues
9m
-35.39%
Net income
20m
P
CFO
-1m
L-86.21%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cann Group Limited, established in Port Melbourne, Australia, in 2014, specializes in the comprehensive lifecycle of medicinal cannabis. This includes genetic development, cultivation, manufacturing, clinical assessment, and the distribution of therapeutic cannabis products. The company supplies these products for use within Australia and also exports them to international markets, operating under specific licenses that permit research and the cultivation of cannabis for human medicinal and scientific purposes.
Key people
Non-Independent Non-Executive Chairman of the Board
Peter Crock
Chief Executive Officer
Philip Jacobsen
Non-Executive Independent Deputy Chairman of the Board
Steven Notaro
Legal and Regulatory Affairs Officer
Geraldine Farrell
Company Secretary · since 2019
Non-Executive Independent Director
Non-Executive Independent Director
Legal address
Walter & Eliza Hall Institute Building, 4 Research Avenue
Bundoora, VIC 3083
AU
Bundoora, VIC 3083
AU
Headquarters
Walter & Eliza Hall Institute Building, 4 Research Avenue
Bundoora, VIC 3038
AU
Bundoora, VIC 3038
AU
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||